878010-24-3 Usage
Uses
Used in Pharmaceutical Industry:
Morpholine-2-carboxylic acid hydrochloride is used as an intermediate in the synthesis of certain medicines, contributing to the development of new therapeutic agents.
Used in Corrosion Inhibition:
Morpholine-2-carboxylic acid hydrochloride serves as a corrosion inhibitor, protecting materials from degradation and extending their service life in various industrial applications.
Used in Organic Synthesis:
morpholine-2-carboxylic acid hydrochloride is utilized as a raw material in organic synthesis, enabling the creation of a wide range of chemical products for diverse applications.
It is crucial to handle morpholine-2-carboxylic acid hydrochloride with care and adhere to proper safety measures to mitigate potential hazards associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 878010-24-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,8,0,1 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 878010-24:
(8*8)+(7*7)+(6*8)+(5*0)+(4*1)+(3*0)+(2*2)+(1*4)=173
173 % 10 = 3
So 878010-24-3 is a valid CAS Registry Number.
878010-24-3Relevant academic research and scientific papers
Therapeutic Compounds
-
Page/Page column 79, (2011/04/25)
Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
Therapeutic Compounds
-
Page/Page column 81, (2008/06/13)
Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
-
Page 87, (2008/06/13)
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
